British Journal of Diabetes & Vascular Disease


Vol 14, No 4 (2014)

Table of Contents

Editorials

We know what to do, so why aren’t we doing it?
Rowan Hillson
HTML PDF
128-130

Reviews

Insulin induced lipodystrophy
Prathima Kadiyala, Shernaz Walton, Thozhukat Sathyapalan
HTML PDF
131-133

Learning from practice

Dipeptidyl peptidase 4 inhibitors in routine clinical practice: experiences from a Scottish teaching hospital
Amy L Brown, Christopher R Sainsbury, Carl Fenelon, Alexander B Mullen, Gregory C Jones
HTML PDF
134-137

Dapagliflozin: Clinical practice compared with pre-registration trial data
Andrew P McGovern, Nina Dutta, Neil Munro, Kenneth Watters, Michael Feher
HTML PDF
138-143

Current topics

Type 1 diabetes: time to act to raise standards of care
Anne Kilvert, Charles Fox, Robert Gregory, Patrick Sharp
HTML PDF
144-147

Assessing the value of the Ambulatory Glucose Profile in clinical practice
Stephan Matthaei
HTML PDF
148-152

Consensus recommendations for the use of Ambulatory Glucose Profile in clinical practice
Stephan Matthaei, Ramiro Antuña DeAlaiz, Emanuele Bosi, Mark Evans, Nel Geelhoed-Duijvestijn, Michael Joubert
HTML PDF
153-157

JBDS guideline for the use of VRIII in medical patients – a commentary
Jonathan Webber
HTML PDF
158-160

Case reports

A case of haemochromatosis and diabetes: a missed opportunity
Hiang Leng Tan, Feaz Babwah, Muhammad Imran Butt, Najeeb Waheed
HTML PDF
161-163

Meeting Reports

ABCD Autumn Meeting 6-7 November 2014
Andrew Macklin
HTML PDF
164-165

Reflections on the 50th annual meeting of the EASD
Mike Gwilt
HTML PDF
166-167

ABCD News

ABCD News
Umesh Dashora
HTML PDF
168-170